9,031 reports of this reaction
3.4% of all Spiriva reports
#4 most reported adverse reaction
DRUG INEFFECTIVE is the #4 most commonly reported adverse reaction for Spiriva, manufactured by Boehringer Ingelheim Pharmaceuticals, Inc.. There are 9,031 FDA adverse event reports linking Spiriva to DRUG INEFFECTIVE. This represents approximately 3.4% of all 266,551 adverse event reports for this drug.
Patients taking Spiriva who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among Spiriva users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for Spiriva:
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 9,031 FDA reports for Spiriva. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.4% of all adverse event reports for Spiriva, making it a notable side effect.
If you experience drug ineffective while taking Spiriva, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.